LivaNova PLC (LIVN)
NMS – Real vaqt narxi. Valyuta: USD
81.20
+2.62 (3.33%)
Bozor ochiq: Aug 12, 2026, 12:40 PM EDT
78.58
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
81.20
+2.62 (3.33%)
Bozor ochiq: Aug 12, 2026, 12:40 PM EDT
78.58
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
LivaNova PLC, tibbiy texnologiyalar kompaniyasi, mahsulotlar, terapiyalar va xizmatlarni ishlab chiqadi, ishlab chiqaradi, sotadi va bozorga chiqaradi. Kompaniya ikkita segmentda ishlaydi: Kardiopulmonar va Neyromodulyatsiya. Kardiopulmonar segment yurak-o'pka apparatlari, oksigenatorlar, avtotransfuziya tizimlari, perfuziya naychalari tizimlari, kanyulalar va boshqa tegishli aksessuarlar, shuningdek, mahsulotlar bilan bog'liq xizmatlarni o'z ichiga olgan kardiopulmonar mahsulotlarni taqdim etadi. Neyromodulyatsiya segmenti VNS Therapy System-ni taklif etadi, bu implantatsiya qilinadigan impuls generatori va vagus nervini stimulyatsiya qiluvchi ulagich simi, implantatsiya jarayoniga yordam beradigan jarrohlik uskunasi va jihozlar hamda ko'rsatma qo'llanmalari; hamda dori-darmonga chidamli epilepsiya va depressiyani davolash uchun neyromodulyatsiya terapiyasini taqdim etuvchi qurilmalar. Ushbu segmentda obstruktsion uyqu apnesini davolash uchun aura6000 tizimini ishlab chiqish va klinik sinovlari ham o'z ichiga oladi. U perfuziologlar, nevrologlar, neyroxirurglar, shifoxonalar, boshqa sog'liqni saqlash mutaxassislari va tibbiyot muassasalariga, shuningdek, sog'liqni saqlash provayderlariga xizmat ko'rsatadi. Kompaniya o'zining tibbiy asboblarini Amerika Qo'shma Shtatlari, Buyuk Britaniya, Germaniya, Fransiya, Italiya, Niderlandiya, Ispaniya, Belgiya, Polsha, Shvetsiya, Shveytsariya, Avstriya, Norvegiya, Portugaliya, Finlyandiya, Daniya va xalqaro miqyosdagi to'g'ridan-to'g'ri savdo vakillari, agentlar va mustaqil distribyutorlar orqali sotadi. LivaNova PLC 2015 yilda tashkil etilgan va Buyuk Britaniyaning Gloucester shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Briana Gotlin | Vice President of Investor Relations |
| Deanna Wilke | Vice President of Corporate Communications |
| Mr. Ahmet Tezel Ph.D. | Chief Innovation Officer |
| Mr. Alex Shvartsburg C.M.A. | Chief Financial Officer |
| Mr. Paul R. Buckman | President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement |
| Mr. Philip Kowalczyk | Chief Strategy & Corporate Development Officer |
| Mr. Vladimir A. Makatsaria | CEO & Director |
| Ms. Lindsey Little | VP & Chief Accounting Officer |
| Ms. Natalia Sergeyevna Kozmina | Chief Human Resources Officer |
| Ms. Sarah K. Mohr | VP of Legal & Company Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-05 | IRANNOTICE | livn-2026630xirannotice.htm |
| 2026-08-05 | 10-Q | livn-20260630.htm |
| 2026-06-11 | 8-K | livn-20260610.htm |
| 2026-05-29 | SD | a2025conflictmineralsrepor.htm |
| 2026-05-06 | IRANNOTICE | livn-2026331xirannotice.htm |
| 2026-05-06 | 8-K | livn-20260506.htm |
| 2026-05-06 | 10-Q | livn-20260331.htm |
| 2026-04-29 | DEFA14A | tm261392d4_defa14a.htm |
| 2026-04-29 | DEF 14A | tm261392-2_def14a.htm |
| 2026-04-29 | ARS | tm261895d1_ars.pdf |